<DOC>
	<DOCNO>NCT00789906</DOCNO>
	<brief_summary>Schizophrenia affect cognition , emotion , behavior . Neuropsychological assessment enables well understand antipsychotic effectiveness brain process , underlie cognitive functioning schizophrenia . Neurocognitive deficit schizophrenia patient appear explain 61 % variance functional outcome important predictor social reintegration ( Peuskens et al , 2005 ) independent living activitiy ( Green et al , 2004 ) . Impaired social functioning within schizophrenia population associate increase health-care cost . Since social occupational disability may generate large indirect cost illness , treatment cognitive deficit enormous impact cost disability associate schizophrenia ( McGurk Mueser , 2004 ) . However , gap cognitive science clinical practice limit implementation cognitive assessment routine evaluation schizophrenia patient . Pharmaceutical industry initiate numerous large scale , multisite study impact novel antipsychotic cognitive deficit schizophrenia patient . The aim research develop population norm computerize neuropsychological assessment effectiveness antipsychotic treatment schizophrenia .</brief_summary>
	<brief_title>Development Population Norms Computerized Neuropsychological Assessment Effectiveness Antipsychotic Treatment Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>An IQ , within normal range . Psychiatric comorbidity . Physical disability illness . A history severe head injury .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Computerized Neuropsychological Assessment</keyword>
	<keyword>Development Population Norms Computerized Neuropsychological Assessment</keyword>
</DOC>